期刊文献+

非小细胞肺癌中AKT活化及与抗凋亡蛋白Survivin、Bcl-2表达的关系 被引量:1

Expression of Activated AKT,Survivin and Bcl-2 in Human Non-Small Cell Lung Cancer
下载PDF
导出
摘要 目的:探讨AKT的功能活化状态p-AKT及抗凋亡蛋白Survivin、Bcl-2在非小细胞肺癌(NSCLC)中的表达及相关性。方法:应用免疫组化的方法,检测80例NSCLC组织及35例非肿瘤性肺组织标本中p-AKT、Survivin、Bcl-2的表达,并与临床病理因素进行相关性分析。结果:p-AKT、Survivin、Bcl-2在NSCLC中高表达,阳性率分别为78.8%、61.3%、50.0%,显著高于在非肿瘤性肺组织中阳性表达0、0、11.4%(P<0.05)。p-AKT、Bcl-2在不同年龄、性别、TNM分期、组织分化组以及有无淋巴结转移组均高表达,组间对比差异无统计学意义(P>0.05)。Survivin表达与TNM分期、组织的分化程度有关(P<0.05)。p-AKT阳性表达与Survivin、Bcl-2呈正相关;Survivin与Bcl-2二者也呈正相关。结论:在NSCLC中存在AKT的活化,Survivin、Bcl-2的高表达可能与AKT的活化有关。在NSCLC中可能存在p-AKT对Survivin、Bcl-2的正向调控。 Abstract Objective: To investigate the expression and clinical significance of p-AKT, survivin and Bcl-2 in human non-small cell lung cancer (NSCLC) tissue. Methods: The expressions of p-AKT, survivin and Bcl-2 in 80 cases of NSCLC and 35 cases of no-cancerous lung disease were assessed by immunohistochemistry, and their correlations with cliniopathologi- cal factors were statistically analyzed. Results: The positive rates of p-AKT, survivin and Bcl-2 were 78.8%, 61.3% and 50.0% in NSCLC and 0,0 and 11.4% in no-cancerous lung disease (P〈0.05). The positive rates of p-AKT and Bcl-2 were showed with a similar high frequency in different age, gender, different histological type, differentiation, TNM stage and groups with or without lymph node metastasis. There were no significant differences among groups (/〉〉0.05). The expression of survivin was correlated with TNM stages and differentiation of NSCLC (P〈0.05). In addition, the positive expression of p-AKT had a correlation with the expression of survivin and Bcl-2. The positive correlations were observed between the expressions of sur- vivin and Bcl-2 in NSCLC tissues. Conclusion: AKT activation may present in NSCLC tissues. The high positive rates of survivin and Bcl-2 may correlate to activation of AKT. There may be positive regulations of survivin and Bcl-2 by p-AKT in NSCLC tissues.
出处 《天津医药》 CAS 北大核心 2007年第4期241-243,I0002,共4页 Tianjin Medical Journal
基金 国家自然科学基金资助项目(项目编号:30571552) 河南省教育厅自然科学研究项目(项目编号:2006320049)
关键词 肺肿瘤癌 非小细胞 蛋白质丝氨酸苏氨酸激酶 原癌基因蛋白质 bcl-2 癌基因 微管相关蛋白质类 lung neoplasms cancer, non-smaLl cell protein-serine-threonine kinases proto-oncogene proteinsc-bcl-2 oncogenes microtubule-assoeiateel proteins
  • 相关文献

参考文献8

  • 1苗丽君,王静.Akt与肿瘤的研究进展[J].国外医学(生理病理科学与临床分册),2004,24(5):406-409. 被引量:38
  • 2Sun M, Wang G, Paciga JE,et al. AKT1/PKBalpha kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells [J]. Am J Pathol, 2001,159(2):431-437.
  • 3Lee SH, Kim HS, Park WS, et al. Non-small ceil lung cancers frequently express phosphorylated Akt; an immunohistochemical study[J]. APMIS, 2002, 110(7-8): 587-592.
  • 4Balsara BR, Pei J, Mitsuuchi Y, et al. Frequent activation of AKT in non-small cell lung carcinomas and preneoplastic bronchial lesions[J]. Carcinogenesis,2004, 25(11): 2053-2059.
  • 5赵瑞力.Survivin在喉癌组织中的表达及其与细胞凋亡的相关性[J].天津医药,2006,34(7):459-461. 被引量:3
  • 6Peng XH, Karna P, Cao Z,et al.Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1 {alpha} signal pathways increases resistance to apoptosis by up-regulating survivin gene expression[J]. J Biol Chem, 2006, 281(36):25903-25914.
  • 7Fornaro M, Plescia J, Chheang S, et al. Fibronectin protects prostate cancer cells from tumor necrosis factor-alpha-induced apoptosis via the AKT/survivin pathway [J]. J Biol Chem, 2003, 278 (50):50402-50411.
  • 8Pugazhenthi S, Nesterova A, Sable C,et al. Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein[J]. J Biol Chem, 2000,275(15):10761-10766.

二级参考文献27

  • 1Ambrosini G,Adida C,Altieri DC.A novel anti-apoptosis gene,survivin,expressed in cancer and lymphoma.Nat Med,1997,3 (8):917-921
  • 2Ambrosini G,Adida C,Sirugo G,et al.Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting.J Biol Chem,1998,273(18):11177-11182
  • 3Clem RJ,Miller LK,Control of programmed cell death by the baculovirus genes p53 and iap.Mol Cell Biol,1994,14:5212-5222
  • 4Tamm I,Wang Y,Sausville E,et al.IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95),Bax,caspases,and anticancer drugs.Cancer Res,1998,58 (23):5315-5320
  • 5Kato J,Kuwabara Y,Mitani M,et al.Expression of survivin in esophageal cancer:correlation with the prognosis and response to chemotherapy.Int J Cancer,2001,95(2):92-95
  • 6Monzo M,Rosell R,Felip E,et al.A novel anti-apoptosis gene:Reexpression of survivin messenger RNA as a prognosis marker in nonsmall-cell lung cancers.J Clin Oncol,1999,17(7):2100-2104
  • 7Lo Muzio L,Staibano S,Pannone G,et al.Expression of the apoptosis inhibitor survivin in aggressive squamous cell carcinoma.Exp Mol Pathol,2001,70(3):249-254
  • 8Potter C J, Pedraza LG, Xu T. Akt regulates growth by directly phosphorylating Tsc2 [ J ]. Nat Cell Biol, 2002,4 (9) :658-665.
  • 9Vander Heiden MG, Plas DR, Rathmell JC, et al . Growth factors can influence cell growth and survival through effects on glucose metabolism[J]. Mol Cell Biol, 2001 ,21 (17) :5899-5912.
  • 10Edinger AL, Thompson CB. Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake [ J ]. Mol Biol Cell,2002 , 13 (7) : 2276-2288.

共引文献39

同被引文献11

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部